The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
position in an intellectually challenging and inspiring environment. KU Leuven is a research-intensive, internationally oriented university that carries out both fundamental and applied research. It is
-
and inspiring environment. KU Leuven is a research-intensive, internationally oriented university that carries out both fundamental and applied research. It is highly inter- and multidisciplinary
-
its 600th anniversary in 2025, making it one of Europe's oldest universities. Currently, KU Leuven is a top-ranked university with a 45th position worldwide on THE Times Higher Education ranking
-
and inspiring environment. KU Leuven is a research-intensive, internationally oriented university that carries out both fundamental and applied research. It is highly inter- and multidisciplinary
-
and inspiring environment. KU Leuven is a research-intensive, internationally oriented university that carries out both fundamental and applied research. It is highly inter- and multidisciplinary
-
understand the effect of epigenetic factors in lipid metabolism reprogramming and its implication in the development of high-risk PCa. DC3 (KU Leuven) will develop and apply AI-based computational tools
-
6 Apr 2024 Job Information Organisation/Company KU Leuven Research Field Engineering Researcher Profile First Stage Researcher (R1) Country Belgium Application Deadline 31 May 2024 - 00:00 (UTC
-
30 Mar 2024 Job Information Organisation/Company KU Leuven Research Field Architecture Researcher Profile Leading Researcher (R4) Country Belgium Application Deadline 26 Sep 2024 - 00:00 (UTC) Type
-
Professor (100%) in the domain of Interior Architecture – Artefactual Agency, KU Leuven, 20 days ago[email protected] . Add to your application the following documents (more information is available on the KU Leuven job site):- A biosketch that addresses the three core tasks of the ZAP mission (research
-
their research. The involved partners are KU Leuven, Belgium (Bart Depreitere, Geert Meyfroidt); Leiden University Medical Center, the Netherlands (Ewout Steyenbergh, Wilco Peul); Charité Berlin, Germany (Jens